Petrelintide
Highest phase reached
Phase 2
Drug type
Protein
- Listing at source
- Listed
- Highest phase reached
- Phase 2
- Drug type
- Protein
- Drug name
- Petrelintide
- petrelintida
- Petrelintida
- petrelintide
- Petrelintide
- petrelintide [INN]
- PETRELINTIDE [USAN]
- Petrelintide [WHO-DD]
- petrelintide inn
- petrelintide usan
- petrelintide who dd
- zp 8396
- ZP-8396
- zp8396
- Zp8396
- ZP8396
- CAS registry numbers
- 2766385-23-1
- ChEMBL ID
- CHEMBL5314864
- FDA ingredient codes (UNII)
- D78KBY7BRU
- First in class
- No
- Orphan designation
- No
- Pharmacology name
- petrelintide
- Type
- Peptide
- Drug name stem
- -tide
Investigated indications
- Condition
- Obesity
- Highest recorded phase
- 1
- Condition identifier
- EFO:0001073
- Subject identifier
- D009765
- Condition identifier
- EFO_0001073
- Highest recorded phase
- 2
- Condition identifier
- HP_0001513
- Highest recorded phase
- 2
- Condition identifier
- HP_0025502
- Highest recorded phase
- 1
- Condition identifier
- HP_0025502
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0005148
- Highest recorded phase
- 2
- NCT05096598
- NCT05613387
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (8)
- A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
- A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
- A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
- Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
- Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
- Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
- Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
- Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function
In development for (1)
- Obesity disorder Phase 1